China Regenerative Medicine International Limited (HKG:8158)

Hong Kong · Delayed Price · Currency is HKD

0.2300

-0.0150 (-6.12%)

Nov 3, 2026, 3:50 PM HKT

HKG:8158 Financials Overview

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	86.4	72.06	90.62	69.49	41.54	282.9
Revenue Growth	19.91%	-20.48%	30.41%	67.29%	-85.32%	55.32%
Gross Profit	48.35	41.92	57.65	19.42	37.62	67.73
Operating Income	8.08	-0.44	6.14	-26.11	11.81	61.63
Net Income	27.54	27.53	17.75	-107.7	4.56	51.83
Earnings Per Share	0.09	0.09	0.06	-0.38	0.02	0.18
EPS Growth	0.04%	55.17%	-	-	-91.21%	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Aesthetic Medical and Beauty Services	77.02	64.04	85.35
Medical Services	9.37	8.02	5.26
Total	86.4	72.06	90.62

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	86.7	8.17	22.7	3.33	1.85	9.93
Total Debt	38.25	51.31	53.69	50.19	72.01	35.82
Net Cash (Debt)	48.45	-43.14	-30.99	-46.86	-70.16	-25.9
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.16	-0.14	-0.10	-0.16	-0.25	-0.09

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	15.62	4.09	18.3	10.79	-12.43	-3.02
Capital Expenditures	-0.07	-0.07	-0.63	-0.27	-2.59	-0.81
Free Cash Flow	15.55	4.02	17.68	10.52	-15.03	-3.83
Free Cash Flow Growth	286.44%	-77.23%	68.11%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	55.96%	58.17%	63.62%	27.95%	90.58%	23.94%
Operating Margin	9.36%	-0.61%	6.77%	-37.58%	28.42%	21.79%
Pretax Margin	17.60%	21.08%	19.59%	-154.99%	19.90%	22.73%
Profit Margin	31.87%	38.20%	19.59%	-154.99%	10.97%	18.32%
FCF Margin	18.00%	5.59%	19.51%	15.13%	-36.17%	-1.35%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	2.54	4.64	5.06	-	69.56	15.42
P/FCF Ratio	4.50	31.75	5.08	15.91	-	-
PS Ratio	0.81	1.77	0.99	2.41	7.63	2.83